Over-regulation of miR-133b inhibits cell proliferation of cisplatin-induced NSCLC by PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.